Boostrix, Injektionssuspension

7680006370043 CH-637 Injektionssuspension
Boostrix, Injektionssuspension
Boostrix, Injektionssuspension
Boostrix, Injektionssuspension
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/06/2025
Summary of Product Characteristics
Français
26/06/2025
Summary of Product Characteristics
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
8.0 UG Substance Wirkstoff (Principe actif)
(N/A)
8.0 UG Substance Wirkstoff (Principe actif)
(N/A)
2.5 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.8 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance RESI
(N/A)
- Substance RESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
637
Drug name
Boostrix, Injektionssuspension
Galenic form
SUPA
ATC Code
J07AJ52
Authorization status
Z
Dispensing category
B
First authorization
10/08/2000
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Auffrischimpfung gegen Diphtherie, Tetanus und Pertussis, ab dem vollendeten 4. Lebensjahr

Package details

Description (FR)
BOOSTRIX susp inj (n ser pré) 10 ser pré 0.5 ml
Description (DE)
BOOSTRIX Inj Susp (n Fertspr) 10 Fertspr 0.5 ml
Market launch
10/08/2000
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (3)

BOOSTRIX susp inj ser pré 0.5 ml
None None
GTIN: 7680006370012
Not in V1
BOOSTRIX susp inj 10 ser pré 0.5 ml
None None
GTIN: 7680006370029
Not in V1
BOOSTRIX susp inj (n ser pré) ser pré 0.5 ml
1 FESP
GTIN: 7680006370036
View